Intraaortic balloon pump: Incidence and predictors of complications in the florence registry

Clinical Cardiology

Volumn 35, Issue 4, 2012, Pages 200-204

  Valente, Serafina ^a   Lazzeri, Chiara ^a   Crudeli, Elena ^a   Chiostri, Marco ^a   Giglioli, Cristina ^a   Bernardo, Pasquale ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; INOTROPIC AGENT; LACTIC ACID; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANEMIA; AORTA BALLOON; ARTICLE; ASSISTED CIRCULATION; BLEEDING; CARDIOGENIC SHOCK; EMBOLISM; FALSE ANEURYSM; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY INFARCTION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE COMPLICATION; PREDICTION; PREDICTIVE VALUE; RETROPERITONEAL HEMATOMA; THROMBOCYTE COUNT; TREATMENT DURATION;

ACUTE CORONARY SYNDROME; AGED; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH STATUS INDICATORS; HEMODYNAMICS; HUMANS; IATROGENIC DISEASE; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; ITALY; MALE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SHOCK, CARDIOGENIC; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84859759116     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20975     Document Type: Article

References (19)

1. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010; 31: 2501-2555.
2. Cohen M, Urban P, Christenson JT, et al.; Benchmark Registry Collaborators. Benchmark Registry Collaborators. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003; 24: 1763-1770.
3. Brodie BR, Stuckey TD, Hansen C, et al. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999; 84: 18-23.
4. O'Murchu B, Foreman RD, Shaw RE, et al. Role of intraaortic balloon pump counterpulsation in high risk coronary rotational atherectomy. J Am Coll Cardiol. 1995; 26: 1270-1275.
5. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003; 145: 700-707.
6. Valente S, Lazzeri C, Chiostri M, et al. Intra-aortic balloon pump in intensive cardiac care: a registry in Florence. Int J Cardiol. 2011; 146: 238-239.
7. Erdogan HB, Goksedef D, Erentug V, et al. In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases. J Card Surg. 2006; 21: 342-346.
8. Roy SK, Howards EW, Panza JA, et al. Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon counterpulsation in the coronary care unit. Clin Cardiol. 2010; 33: 30-35.
9. Perera D, Stables R, Thomas M, et al.; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention. A randomized controlled trial. JAMA. 2010; 304: 867-874.
10. Stone GW, White HD, Ohman EM, et al. Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Investigators. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Lancet. 2007; 369: 907-919.
11. Perera D, Stables R, Booth J, et al.; BCIS-1 Investigators. The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design. Am Heart J. 2009; 158: 910.e2-916.e2
12. McCabe JC, Abel RM, Subramanian VA, et al. Complications of intra-aortic balloon insertion and counterpulsation. Circulation. 1978; 57: 769-773.
13. Vonderheide RH, Thadhani R, Kuter DJ., Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998; 105: 27-32.
14. Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA., Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol. 2008; 21: 350-356.
15. Vales L, Kanei Y, Ephrem G, et al. Intra-aortic balloon pump use and outcomes with current therapy. J Invasive Cardiol. 2011; 23: 116-119.
16. Moulopoulos SD, Topaz S, Kolff WJ., Diastolic balloon pumping (with carbon dioxide) in the aorta-a mechanical assistance to the failing circulation. Am Heart J. 1962; 63: 669-675.
17. Ferguson JJ III, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. JACC. 2001; 38: 1456-1462.
18. Hakim DA, Dangas GD, Caixeta A, et al. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J. 2011; 161: 391-396.
19. Caixeta A, Dangas GD, Mehran R, et al. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J. 2011; 161: 298-306.